Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/Hyperactivity disorder: Is there an interaction?

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 5, 2012, Pages 343-352

  Hong, Soon Beom ^a   Kim, Jae Won ^a   Cho, Soo Churl ^a   Shin, Min Sup ^a   Kim, Boong Nyun ^a   Yoo, Hee Jeong ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; NORADRENALIN TRANSPORTER;

ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DEFICIT HYPERACTIVITY DISORDER RATING SCALE IV; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DRUG DOSE TITRATION; DSM-IV; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERACTIVITY; INSOMNIA; KOREA; MAJOR CLINICAL STUDY; NORADRENERGIC SYSTEM; OPEN STUDY; PSYCHOLOGICAL RATING SCALE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT;

ASIAN CONTINENTAL ANCESTRY GROUP; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; INTELLIGENCE TESTS; LOGISTIC MODELS; MALE; METHYLPHENIDATE; MINISATELLITE REPEATS; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; ONCOGENE PROTEINS; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DOPAMINE D4; TREATMENT OUTCOME;

EID: 84867753993     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0076     Document Type: Article

References (45)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
2. Banaschewski T, Becker K, Scherag S, Franke B, Coghill D: Molecular genetics of attention-deficit/hyperactivity disorder: An overview.Eur Child Adolesc Psychiatry 19:237-257, 2010.
3. Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH: Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Neuropsychopharmacology 30:2290-2297, 2005. (Pubitemid 41643982)
4. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60:1111-1120, 2006. (Pubitemid 44647216)
5. Biederman J, Spencer T: Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242, 1999. (Pubitemid 30114440)
6. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711, 2002. (Pubitemid 35335888)
7. Cheon KA, Cho DY, Koo MS, Song DH, Namkoong K: Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder. Biol Psychiatry 65:564-570, 2009.
8. Cheon KA, Kim BN, Cho SC: Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Neuropsychopharmacology 32:1377-1383, 2007.
9. Cheon KA, Ryu YH, Kim JW, Cho DY: The homozygosity for 10-repeat in allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: Relating to treatment response to methylphenidate.Eur Neuropsychopharmacol 15:95-101, 2005.
10. Cho SC, Kim JW, Kim BN, Hwang JW, Park M, Kim SA, Cho DY, Yoo HJ, Chung US, Son JW, Park TW: Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:957-963, 2008a.
11. Cho SC, Kim JW, Kim BN, Hwang JW, Park M, Kim SA, Cho DY, Yoo HJ, Chung US, Son JW, Park TW: No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: A family-based and case-control association study in a Korean sample. Neuropsychobiology 57:131-138, 2008b.
12. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Chiu F, Wang E, Farwell K, Darakjy S, Baker R, Dietz G, Saucier G, MacMurray JP: Multivariate analysis of association of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 58:31-40, 2000. (Pubitemid 30468427)
13. Contini V, Victor MM, Cerqueira CC, Polina ER, Grevet EH, Salgado CA, Karam RG, Vitola ES, Belmonte-de-Abreu P, Bau CH:Adrenergic alpha2A receptor gene is not associated with methylphenidate response in adults with ADHD. Eur Arch Psychiatry Clin Neurosci, 26:205-211, 2011.
14. da Silva TL, Pianca TG, Roman T, Hutz MH, Faraone SV, Schmitz M, Rohde LA: Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type. J Neural Transm 115:341-345, 2008.
15. DuPaul G, Power T, Anastopoulos A, Reid R: The ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation New York:Guilford Press; 1998.
16. Faraone SV, Mick E: Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 33:159-180, 2010.
17. Froehlich TE, McGough JJ, Stein MA: Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs 24:99-117, 2010.
18. Gabriela ML, John DG, Magdalena BV, Ariadna GS, Francisco de LP, Liz SM, Lino PC, Josefina RG, Ernesto RZ, Carlos CF: Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Neurosci Lett 451:257-260, 2009.
19. Gobert A, Rivet JM, Audinot V, Newman-Tancredi A, Cistarelli L, Millan MJ: Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freelymoving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84:413-429, 1998. (Pubitemid 28122907)
20. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM: Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111-116, 1995.
21. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: US Department of Health, Education, and Welfare; 1976.
22. Hamarman S, Fossella J, Ulger C, Brimacombe M, Dermody J: Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder:A pharmacogenetic study. J Child Adolesc Psychopharmacol 14:564-574, 2004.
23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997. (Pubitemid 27272932)
24. Kim BN, Kim JW, Hong SB, Cho SC, Shin MS, Yoo HJ: Possible association of norepinephrine transporter - 3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder. Behav Brain Funct 6:57, 2010.
25. Kim JW, Kim BN, Cho SC: The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: A case-control association study in a Korean sample. J Psychiatr Res 40:730-737, 2006.
26. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, Cho SC, Seo DH, Bae MO, So YK, Noh JS, Koh YJ, McBurnett K, Leventhal B: The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K). Yonsei Med J 45:81-89, 2004. (Pubitemid 38372291)
27. Kirley A, Lowe N, Hawi Z, Mullins C, Daly G,Waldman I, McCarron M, O'Donnell D, Fitzgerald M, Gill M: Association of the 480 bp DAT1allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 121B:50-54, 2003. (Pubitemid 37064030)
28. Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B: Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). Am J Med Genet B Neuropsychiatr Genet 147B:201-208, 2008. (Pubitemid 351355281)
29. Lee SH, Kim SW, Lee MG, Yook KH, Greenhill LL, Frandin KN, Hong HJ: Lack of association between response of OROSmethylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD. Psychiatry Res 186:338-344, 2011.
30. Madras BK, Miller GM, Fischman AJ: The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1397-1409, 2005. (Pubitemid 40798561)
31. McGough J, McCracken J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigawa S, Moyzis R, Vitiello B: Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1314-1322, 2006. (Pubitemid 44665448)
32. McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA: A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 48:1155-1164, 2009.
33. Mick E, Biederman J, Spencer T, Faraone SV, Sklar P: Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 141B:890-894, 2006. (Pubitemid 44905443)
34. Polanczyk G, Zeni C, Genro JP, Guimaraes AP, Roman T, Hutz MH, Rohde LA: Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64:218-224, 2007. (Pubitemid 46220779)
35. Prince J: Catecholamine dysfunction in attention-deficit/hyperactivity disorder: An update. J Clin Psychopharmacol 28:S39-45, 2008.
36. Roman T, Szobot C, Martins D, Biederman J, Rohde LA, Hutz MH:Dopamine transporter gene and response to methylphenidate in attention-deficit/ hyperactivity disorder. Pharmacogenetics 12:497-499, 2002. (Pubitemid 34913533)
37. Santosh PJ, Taylor E: Stimulant drugs. Eur Child Adolesc Psychiatry 9 Suppl 1:I27-43, 2000.
38. So Y, Noh J, Kim Y, Ko S, Koh Y: The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 41:283-289, 2002.
39. Song J, Song DH, Jhung K, Cheon KA: Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder. Int Clin Psychopharmacol 26:107-113, 2011.
40. Stein MA, Waldman ID, Sarampote CS, Seymour KE, Robb AS, Conlon C, Kim SJ, Cook EH: Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology 30:1374-1382, 2005. (Pubitemid 40848091)
41. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O: Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614, 1991. (Pubitemid 21912282)
42. Wilens TE: Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 28:S46-53, 2008.
43. Winsberg BG, Comings DE: Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry 38:1474-1477, 1999.
44. Yang L, Wang YF, Li J, Faraone SV: Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry 43:1154-1158, 2004. (Pubitemid 39096873)
45. Zeni CP, Guimaraes AP, Polanczyk GV, Genro JP, Roman T, Hutz MH, Rohde LA: No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B:391-394, 2007. (Pubitemid 46646664)